Pediatrix Medical Group (NYSE:MD) Price Target Raised to $18.00

Pediatrix Medical Group (NYSE:MD) had its price target raised by stock analysts at Truist Financial from $15.00 to $18.00 in a report released on Friday,Benzinga reports. The firm currently has a “hold” rating on the stock. Truist Financial’s price target points to a potential upside of 11.01% from the company’s previous close.

Other equities research analysts also recently issued reports about the company. Deutsche Bank Aktiengesellschaft raised their price target on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Macquarie started coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective on the stock. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Jefferies Financial Group increased their price objective on Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Finally, Mizuho increased their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Tuesday, November 19th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $16.75.

Pediatrix Medical Group Stock Down 5.9 %

Pediatrix Medical Group stock traded down $1.02 during mid-day trading on Friday, hitting $16.22. The company’s stock had a trading volume of 498,678 shares, compared to its average volume of 531,748. The firm’s 50 day moving average is $13.86 and its 200 day moving average is $12.91. The company has a market cap of $1.39 billion, a PE ratio of -5.31, a price-to-earnings-growth ratio of 1.43 and a beta of 1.57. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42. Pediatrix Medical Group has a 52-week low of $6.62 and a 52-week high of $17.67.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The firm had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. On average, analysts anticipate that Pediatrix Medical Group will post 1.26 earnings per share for the current year.

Hedge Funds Weigh In On Pediatrix Medical Group

Several hedge funds and other institutional investors have recently modified their holdings of MD. CWM LLC raised its position in Pediatrix Medical Group by 134.0% in the 3rd quarter. CWM LLC now owns 6,427 shares of the company’s stock valued at $74,000 after purchasing an additional 3,681 shares during the last quarter. Creative Planning raised its position in Pediatrix Medical Group by 48.3% in the 3rd quarter. Creative Planning now owns 30,662 shares of the company’s stock valued at $355,000 after purchasing an additional 9,991 shares during the last quarter. Nisa Investment Advisors LLC raised its position in Pediatrix Medical Group by 352.4% in the 3rd quarter. Nisa Investment Advisors LLC now owns 21,513 shares of the company’s stock valued at $249,000 after purchasing an additional 16,758 shares during the last quarter. Principal Financial Group Inc. raised its position in Pediatrix Medical Group by 14.1% in the 3rd quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock valued at $5,953,000 after purchasing an additional 63,581 shares during the last quarter. Finally, Atria Investments Inc raised its position in Pediatrix Medical Group by 9.0% in the 3rd quarter. Atria Investments Inc now owns 27,124 shares of the company’s stock valued at $314,000 after purchasing an additional 2,238 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.